Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $114.3 million.

  • Fractyl Health's Liabilities and Shareholders Equity fell 996.82% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $367.4 million, marking a year-over-year decrease of 2839.59%. This contributed to the annual value of $108.1 million for FY2024, which is 4181.1% up from last year.
  • As of Q3 2025, Fractyl Health's Liabilities and Shareholders Equity stood at $114.3 million, which was down 996.82% from $62.0 million recorded in Q2 2025.
  • In the past 5 years, Fractyl Health's Liabilities and Shareholders Equity ranged from a high of $163.5 million in Q1 2024 and a low of $62.0 million during Q2 2025
  • For the 3-year period, Fractyl Health's Liabilities and Shareholders Equity averaged around $110.1 million, with its median value being $111.2 million (2024).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 4181.1% in 2024, then crashed by 5765.69% in 2025.
  • Quarter analysis of 3 years shows Fractyl Health's Liabilities and Shareholders Equity stood at $76.2 million in 2023, then surged by 41.81% to $108.1 million in 2024, then rose by 5.73% to $114.3 million in 2025.
  • Its last three reported values are $114.3 million in Q3 2025, $62.0 million for Q2 2025, and $83.0 million during Q1 2025.